Reporting from ECCMID17, we spoke to William Irving about his current work on hepatitis C and his thoughts on the future of this field.
In this interview, Joop Arends discusses his thoughts on the future of diagnosis and management of hepatitis C, and also gives us his highlights from ECCMID.
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis based on the realtionship with Epstein–Barr virus.
In line with Hepatitis Awareness Month, we spoke to Marcus Dorner about his current research into the host–virus interactions in hepatitis B and C infection, their implications for vaccine development and more.
John-Arne Røttingen discusses his role as founding CEO of the Coalition for Epidemic Preparedness Innovations (CEPI) and his thoughts on the importance of developing new vaccines for emerging threats.
In this podcast Dr Elizabeth Whittaker, Dr James Seddon, Dr Pete Dodd and Professor Beate Kampmann discuss their work in pediatric tuberculosis focusing on the areas of immunology, modelling and drug resistance.
With TB still presenting a major health problem across the globe, we spoke to Timothy Rodwell about the challenges currently facing TB diagnostics and his work as acting head of the TB Program at FIND.
In this interview to mark World TB Day Madhukar Pai discusses the challenges surrounding TB case detection and the future of TB diagnostics.
Editor, Martha Powell, speaks to Rob Aldridge about his research in infectious disease epidemiology and identifying the health inequalities faced by vulnerable and marginalized populations.
Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery (CO-ADD) discusses his work towards uncovering compounds with antibiotic potential and shares his thoughts on the best strategies to tackle antibiotic resistance moving forwards.